Browse Items (4 total)
- Tags: Hodnichak Cheryl M
Prolonged isoproterenol infusion impairs the ability of beta(2)-agonists to increase alveolar liquid clearance.
Tags: 2002, Adrenergic, Adrenergic beta-Agonists/*pharmacology, American journal of physiology. Lung cellular and molecular physiology, Animals, beta/metabolism, Boja John W, Down-Regulation/drug effects, Drug Interactions, Epithelial Cells/metabolism, Extravascular Lung Water/*metabolism, Folkesson Hans G, Hodnichak Cheryl M, Isoproterenol/*pharmacology, Maender Kay C, Male, Maron Michael B, Morgan Eric E, Pulmonary Alveoli/cytology/*metabolism, Pulmonary Circulation/physiology, Pulmonary Edema/metabolism, Rats, Receptors, Respiratory Mucosa/cytology/*metabolism, Sprague-Dawley, Stader Sonya M, Terbutaline/pharmacology
Postreceptor defects in alveolar epithelial beta-adrenergic signaling after prolonged isoproterenol infusion.
Tags: 2003, 8-Bromo Cyclic Adenosine Monophosphate/pharmacology, Adenylyl Cyclases/metabolism, Adrenergic, Adrenergic beta-Agonists/*pharmacology, American journal of physiology. Lung cellular and molecular physiology, Animals, beta/*metabolism, Colforsin/pharmacology, Cyclic AMP-Dependent Protein Kinase Type II, Cyclic AMP-Dependent Protein Kinases/metabolism, Cyclic AMP/metabolism, Extravascular Lung Water/metabolism, Folkesson Hans G, Hodnichak Cheryl M, Isoproterenol/*pharmacology, Male, Maron Michael B, Mavrich Kate E, Morgan Eric E, Pulmonary Alveoli/*drug effects/*metabolism, Pulmonary Edema/metabolism, Rats, Receptors, Respiratory Mucosa/drug effects/metabolism, Signal Transduction/drug effects, Sprague-Dawley, Stader Sonya M
Impaired alveolar liquid clearance after 48-h isoproterenol infusion spontaneously recovers by 96 h of continuous infusion.
Tags: *Pulmonary Alveoli/drug effects/metabolism, 2006, Adrenergic, Adrenergic beta-Antagonists/pharmacology, American journal of physiology. Lung cellular and molecular physiology, Animals, beta-2/metabolism, Bronchodilator Agents/administration & dosage/*pharmacology, Folkesson Hans G, Hodnichak Cheryl M, Isoproterenol/administration & dosage/*pharmacology, Lung/drug effects/metabolism, Male, Maron Michael B, Propranolol/pharmacology, Rats, Receptors, Sprague-Dawley, Stader Sonya M, Terbutaline/pharmacology, Time Factors
Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.
Tags: *Chemoprevention, 2011, Analysis of Variance, Animal, Animal Studies, Animal/drug effects, Animals, Antioxidants, Behavior, Bishayee Anupam, Blotting, Booth Tristan D, Carcinoma, Cardiotoxicity, Cardiotoxins/*toxicity, Chemoprevention, Data Analysis Software, Department of Integrative Medical Sciences, Descriptive Statistics, Disease Models, Doppler, Dose-Response Relationship, Drug, Echocardiography, Feeding Behavior/drug effects, Female, Fisher's Exact Test, Funding Source, Heart – Drug Effects, Heart/drug effects/physiopathology, Hepatocellular – Prevention and Control, Hepatocellular/*drug therapy/pathology/physiopathology, Hepatocytes/drug effects/pathology, Hodnichak Cheryl M, Humans, Investigational new drugs, Liver Neoplasms/*drug therapy/pathology/physiopathology, Liver/drug effects/pathology/physiopathology, Luther Daniel J, Meszaros J Gary, NEOMED College of Medicine, Ohanyan Vahagn, Polyphenols – Therapeutic Use, Rats, Resveratrol, Shamhart Patricia E, Sisakian Hamayak, Sprague-Dawley, Stilbenes/*therapeutic use, Systole/drug effects, Western